November 20th 2024
Calling it a barrier to care, FDA committees decide to end clozapine REMS.
2023 Annual Psychiatric Times™ World CME Conference
View More
5th Annual International Congress on the Future of Neurology®
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Real Psychiatry 2025
January 17 - 18, 2025
View More
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Expert Perspectives in the Recognition and Management of Postpartum Depression
View More
Southern California Psychiatry Conference
July 11-12, 2025
Register Now!
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists
View More
BURST CME™ Part I: Understanding the Impact of Huntington’s Disease
View More
Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease
View More
Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea
View More
Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia
View More
Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment
View More
8 Considerations in the Differential Diagnosis of Posttraumatic Psychosis
February 14th 2020Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.
Read More
The Opening of the Maudsley Hospital: January 31, 1923
January 29th 2020In the early years, treatment was largely restricted to restraint and sedation with great emphasis placed on fresh air for prevention of mental illness. Later, the aim of treatment was to prevent transfer of patients to country asylums.
Read More
Maternal Infection During Pregnancy: Increased Risk of Psychosis in Offspring
December 10th 2019Maternal viral infection during pregnancy is a risk factor for schizophrenia. But there has been relatively less research on the association between maternal bacterial infection during pregnancy and psychosis risk.
Read More
Year in Review: 2019 Special Reports in Psychiatry
December 2nd 2019As varied as the field of psychiatry itself, our Special Report collections covered issues such as eating disorders, traumatic brain injury, practice management, schizophrenia and depression, complex medical comorbidities, and more. Here's a sampling.
Read More
Brain Glucose, Insulin Resistance, and Memory in Schizophrenia
October 8th 2019Memory impairments have been shown to compromise quality of life in patients with schizophrenia. Findings from a recent study show that insulin resistance may be an underlying cause of memory loss in this population.
Read More
Examining the Link Between the Immune System and Schizophrenia
September 13th 2019As research continues to point to a connection between the immune system and schizophrenia, a study of innate immunity in patients with first episode psychosis and schizophrenia provides further insights into the potential mechanisms of this link.
Read More